BLS Pharmaceuticals Limited

A$0.92As of Sun 8 Nov 2026, 12:00 UTC
ASX:BLSHealthcare
Country Australia
PE (Fwd) •••
TSR 10Y CAGR 20.67%
Div yield —
ROE 71.30%
Biotechnology
Beta (5Y) 0.39
PE TTM 13.73
TSR TTM 130.00%
Mkt cap A$211.9M
ROIC 45.97%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.09
18.71%
(71.63%)
Hold 10|8|1|4|7
2Q26
3Q26
4Q26
1Q27
Earnings per share$
0.02
0.02
0.03
0.03
15.52%
17.38%
20.69%
15.65%
Revenue$M
12.59
13.07
13.01
13.43
(1.20%)
4.34%
1.26%
7.09%
Peers (US$145.5M)
Cap (US$)
PE
107.6M
—
Capital
TTM
5Y
10Y
Leveragex
0.929
0.153
0.136
EBIT/Intx
0.631
0.188
0.165
Own earn%
(57.47)
(218.32)
(198.43)
Sh yield%
29.19
31.79
33.14
Owners
Insiders/Inst%
12.60
55.20
Short interest%
0.63
SBC / revenue%
0.59
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
7–11
$1 testx
0.0
Incr. ROIC%
18